TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multi-site Trial Using Short Mobile Messages (SMS) to Improve Infant Weight in Low-income Minorities
Brief Summary: The goals of this multi-site clinical trial are to pilot test weekly SMS sent to parents/caregivers of infants to improve feeding practices and decrease excessive weight gain in infants who are participants of the Women, Infants and Children (WIC) program in Puerto Rico and Hawaii. The intervention consists of weekly SMS for 4 months to reinforce the feeding messages provided by WIC.


Options:
A: Arm Label: Nutrition messages; Type: EXPERIMENTAL; Interventions: Behavioral: SMS | Arm Label: General health messages; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS | Intervention Type: BEHAVIORAL; Name: SMS; Assigned to Arm(s): General health messages, Nutrition messages
B: Arm Label: HIV intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: HIV knowledge Intervention | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: HIV knowledge Intervention; Assigned to Arm(s): HIV intervention Group
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone reminder | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Mobile phone reminder | Intervention Type: BEHAVIORAL; Name: Mobile phone reminder; Assigned to Arm(s): Control, Intervention
D: Arm Label: Fixed SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Fixed SMS, real-time monitoring | Arm Label: Triggered SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Triggered SMS, real-time monitoring | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Fixed SMS, real-time monitoring; Assigned to Arm(s): Fixed SMS, real-time monitoring | Intervention Type: DEVICE; Name: Triggered SMS, real-time monitoring; Assigned to Arm(s): Triggered SMS, real-time monitoring

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brain Morphometric Study in Knee Osteoarthritis Patients Treated With Duloxetine
Brief Summary: This is a two week,single-blind study evaluating pain response and changes in brain imaging upon treatment with placebo in people with knee OA.


Options:
A: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sugar pill | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Sugar pill; Assigned to Arm(s): Sugar pill
B: Arm Label: milnacipran; Type: EXPERIMENTAL; Interventions: Drug: Milnacipran | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Milnacipran; Assigned to Arm(s): milnacipran | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine, Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
D: Arm Label: Nortriptyline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nortriptyline Hydrochloride | Arm Label: Placebo (for nortriptyline); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for nortriptyline) | Intervention Type: DRUG; Name: Nortriptyline Hydrochloride; Assigned to Arm(s): Nortriptyline | Intervention Type: DRUG; Name: Placebo (for nortriptyline); Assigned to Arm(s): Placebo (for nortriptyline)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brain Morphometric Study in Knee Osteoarthritis Patients Treated With Duloxetine
Brief Summary: This is a two week,single-blind study evaluating pain response and changes in brain imaging upon treatment with placebo in people with knee OA.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B
B: Arm Label: Sugar Pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Milnacipran; Type: EXPERIMENTAL; Interventions: Drug: Milnacipran | Intervention Type: DRUG; Name: Milnacipran; Assigned to Arm(s): Milnacipran | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Sugar Pill
C: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine, Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Controlled Trial of a Novel Mobile Device Application to Improve Adherence in Children Greater Than 11 Years of Age After Cardiac Transplantation (CTOTC-10)
Brief Summary: The purpose of this study is to collect and compare information on how and when adolescent heart transplant recipients take their prescribed medication. The investigators want to find out if regular use of 'an app' on cell phones, called the Teen Pocket PATH® (TPP), can help adolescents take their medication according to their prescribed dosing schedule. This may then help reduce complications of transplant, such as rejection. The investigators also want to find out if how adolescent heart transplant recipients take their medications affects the development of antibodies in their blood. Antibodies are small proteins in the blood that may develop after heart transplantation, and which can sometimes damage a new heart.


Options:
A: Arm Label: Teen Pocket PATH® Mobile Application; Type: EXPERIMENTAL; Interventions: Other: Teen Pocket PATH® Mobile Application | Arm Label: Control Group: Standard of Care; Type: OTHER; Interventions: Other: Control Group: Standard of Care | Intervention Type: OTHER; Name: Teen Pocket PATH® Mobile Application; Assigned to Arm(s): Teen Pocket PATH® Mobile Application | Intervention Type: OTHER; Name: Control Group: Standard of Care; Assigned to Arm(s): Control Group: Standard of Care
B: Arm Label: Prograf®; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus - Prograf® twice daily formulation | Arm Label: Advagraf®; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus - Advagraf® once daily formulation | Intervention Type: DRUG; Name: Tacrolimus - Prograf® twice daily formulation; Assigned to Arm(s): Prograf® | Intervention Type: DRUG; Name: Tacrolimus - Advagraf® once daily formulation; Assigned to Arm(s): Advagraf®
C: Arm Label: Telemetric Intervention Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Telemetric Intervention | Arm Label: Standard of Care Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telemetric Intervention; Assigned to Arm(s): Telemetric Intervention Arm
D: Arm Label: Tacrolimus BID; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus BID | Arm Label: Advagraf QD; Type: ACTIVE_COMPARATOR; Interventions: Drug: Advagraf QD | Intervention Type: DRUG; Name: Tacrolimus BID; Assigned to Arm(s): Tacrolimus BID | Intervention Type: DRUG; Name: Advagraf QD; Assigned to Arm(s): Advagraf QD

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial
Brief Summary: The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.


Options:
A: Arm Label: social networking on mobile phone; Type: EXPERIMENTAL; Interventions: Other: social networking on mobile phone | Arm Label: no social networking on mobile phone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: social networking on mobile phone; Assigned to Arm(s): social networking on mobile phone
B: Arm Label: Positive adjustment coping intervention; Type: EXPERIMENTAL; Interventions: Other: Positive adjustment coping intervention | Arm Label: Brainteaser; Type: OTHER; Interventions: Other: Brainteaser | Intervention Type: OTHER; Name: Positive adjustment coping intervention; Assigned to Arm(s): Positive adjustment coping intervention | Intervention Type: OTHER; Name: Brainteaser; Assigned to Arm(s): Brainteaser
C: Arm Label: Encouragement Arm; Type: EXPERIMENTAL; Interventions: Other: digital family planning screening and referral service | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: digital family planning screening and referral service; Assigned to Arm(s): Encouragement Arm
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder | Arm Label: SMS reminder + Unconditional Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder, Behavioral: Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder + Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: Unconditional Incentive; Assigned to Arm(s): SMS reminder + Unconditional Incentive

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial
Brief Summary: The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive text messages | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Text messages not about contraception | Intervention Type: BEHAVIORAL; Name: Contraceptive text messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Text messages not about contraception; Assigned to Arm(s): Control
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text Messages; Type: EXPERIMENTAL; Interventions: Other: Daily Text Messages | Intervention Type: OTHER; Name: Daily Text Messages; Assigned to Arm(s): Text Messages
C: Arm Label: Weekly SMS, brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Weekly SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Intervention Type: BEHAVIORAL; Name: Short Message Services to Support ARV therapy adherence; Assigned to Arm(s): Control Group, Daily SMS, Brief message, Daily SMS, Long Message, Weekly SMS, Long Message, Weekly SMS, brief message
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder | Arm Label: SMS reminder + Unconditional Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder, Behavioral: Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder + Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: Unconditional Incentive; Assigned to Arm(s): SMS reminder + Unconditional Incentive

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial
Brief Summary: The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.


Options:
A: Arm Label: texting group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: text messages focused on smoking cessation and pregnancy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages focused on smoking cessation and pregnancy; Assigned to Arm(s): texting group
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cell Phone Intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cell Phone Intervention; Assigned to Arm(s): 1
C: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: promotional Exclusive breastfeeding text messages | Arm Label: control; Type: OTHER; Interventions: Other: promotional Exclusive breastfeeding text messages | Intervention Type: OTHER; Name: promotional Exclusive breastfeeding text messages; Assigned to Arm(s): control, intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder | Arm Label: SMS reminder + Unconditional Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder, Behavioral: Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder + Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: Unconditional Incentive; Assigned to Arm(s): SMS reminder + Unconditional Incentive

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial
Brief Summary: The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder | Arm Label: SMS reminder + Unconditional Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder, Behavioral: Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder + Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: Unconditional Incentive; Assigned to Arm(s): SMS reminder + Unconditional Incentive
B: Arm Label: Short Message Service (SMS) group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS message | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Intervention Type: BEHAVIORAL; Name: SMS message; Assigned to Arm(s): Short Message Service (SMS) group | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care
C: Arm Label: One time standard verbal counseling; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS Reminders; Type: EXPERIMENTAL; Interventions: Behavioral: Short message service | Intervention Type: BEHAVIORAL; Name: Short message service; Assigned to Arm(s): SMS Reminders
D: Arm Label: Alma Sana Bracelet Arm; Type: EXPERIMENTAL; Interventions: Other: Alma Sana Bracelet | Arm Label: Simple Silicon Bracelet Arm; Type: EXPERIMENTAL; Interventions: Other: Simple Silicon Bracelet | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alma Sana Bracelet; Assigned to Arm(s): Alma Sana Bracelet Arm | Intervention Type: OTHER; Name: Simple Silicon Bracelet; Assigned to Arm(s): Simple Silicon Bracelet Arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial
Brief Summary: The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text message; Type: ACTIVE_COMPARATOR; Interventions: Other: SMS reminder message | Arm Label: Text message and voice call; Type: ACTIVE_COMPARATOR; Interventions: Other: Voice call + SMS message | Intervention Type: OTHER; Name: SMS reminder message; Assigned to Arm(s): Text message | Intervention Type: OTHER; Name: Voice call + SMS message; Assigned to Arm(s): Text message and voice call
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder | Arm Label: SMS reminder + Unconditional Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder, Behavioral: Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder + Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: Unconditional Incentive; Assigned to Arm(s): SMS reminder + Unconditional Incentive
C: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
D: Arm Label: Controls; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Reminders alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reminders alone | Arm Label: Reminders + compliance-linked incentives; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reminders alone, Behavioral: Compliance-linked incentives | Intervention Type: BEHAVIORAL; Name: Reminders alone; Assigned to Arm(s): Reminders + compliance-linked incentives, Reminders alone | Intervention Type: BEHAVIORAL; Name: Compliance-linked incentives; Assigned to Arm(s): Reminders + compliance-linked incentives

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Ranging Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Brief Summary: This is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose ranging study to investigate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of Bimekizumab compared with placebo in adult subjects with moderate to severe chronic plaque psoriasis in order to guide the selection of doses and clinical indices in the Phase 3 development program.


Options:
A: Arm Label: Secukinumab 300 mg; Type: EXPERIMENTAL; Interventions: Biological: Secukinumab | Arm Label: Narrow-band ultraviolet B (nb-UVB); Type: ACTIVE_COMPARATOR; Interventions: Radiation: nb-UVB | Intervention Type: BIOLOGICAL; Name: Secukinumab; Assigned to Arm(s): Secukinumab 300 mg | Intervention Type: RADIATION; Name: nb-UVB; Assigned to Arm(s): Narrow-band ultraviolet B (nb-UVB)
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Biological: ABT-874 | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Biological: etanercept | Arm Label: C; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: BIOLOGICAL; Name: ABT-874; Assigned to Arm(s): A | Intervention Type: BIOLOGICAL; Name: etanercept; Assigned to Arm(s): B | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): C
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Bimekizumab dosing regimen 1; Type: EXPERIMENTAL; Interventions: Drug: Bimekizumab, Other: Placebo | Arm Label: Bimekizumab dosing regimen 2; Type: EXPERIMENTAL; Interventions: Drug: Bimekizumab, Other: Placebo | Arm Label: Bimekizumab dosing regimen 3; Type: EXPERIMENTAL; Interventions: Drug: Bimekizumab, Other: Placebo | Arm Label: Bimekizumab dosing regimen 4; Type: EXPERIMENTAL; Interventions: Drug: Bimekizumab, Other: Placebo | Arm Label: Bimekizumab dosing regimen 5; Type: EXPERIMENTAL; Interventions: Drug: Bimekizumab | Intervention Type: DRUG; Name: Bimekizumab; Assigned to Arm(s): Bimekizumab dosing regimen 1, Bimekizumab dosing regimen 2, Bimekizumab dosing regimen 3, Bimekizumab dosing regimen 4, Bimekizumab dosing regimen 5 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Bimekizumab dosing regimen 1, Bimekizumab dosing regimen 2, Bimekizumab dosing regimen 3, Bimekizumab dosing regimen 4, Placebo
D: Arm Label: Ixekizumab; Type: EXPERIMENTAL; Interventions: Drug: Ixekizumab, Drug: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ixekizumab, Drug: Placebo | Intervention Type: DRUG; Name: Ixekizumab; Assigned to Arm(s): Ixekizumab, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Ixekizumab, Placebo

Answer: C